Clinical Trial Update: Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) [Phase 3]

View source ↗

Summary

Phase 3 study comparing lamivudine plus interferon versus lamivudine for HBeAg-positive chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Interferon (interferon)
• Lamivudine (lamivudine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED